MedTrace Logo

Prevalence of Deep Sedation in Terminal Palliative Phase

NCT04333719 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 183

Last updated 2021-01-22

No results posted yet for this study

Summary

This nation-wide, multicentric, prospective and cross-sectional study aims to estimate the prevalence of deep sedations (i.e. with a -4 or -5 score at the Richmond scale at the induction time) for patients in terminal phase and receiving cares from a specialized palliative care facility (palliative care units, dedicated beds in acute units, mobile teams for inpatient or outpatients or home-based structures) in France.

Conditions

  • Palliative Care
  • Deep Sedations

Interventions

OTHER

Type of sedations

Estimate the prevalence of deep sedations (i.e. with a -4 or -5 score at the Richmond scale at the induction time) for patients in terminal phase and receiving cares from a specialized palliative care facility

Sponsors & Collaborators

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Benoît BURUCOA, MD, PhD · University Hospital, Bordeaux

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-13
Primary Completion
2020-11-17
Completion
2020-11-17

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04333719 on ClinicalTrials.gov